Drugs / VXS-1219
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06417853 Comparator | Jul 2024 → Jan 2026 | avian influenza | Vaxxas Pty Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VXS-1219 | “either VXS-1219, VXS-1219 with QS21 adjuvant (VXS-1219A)” NCT06417853 ↗ |
| Known as | VXS-1219A | “either VXS-1219, VXS-1219 with QS21 adjuvant (VXS-1219A)” NCT06417853 ↗ |